Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SMARD1 murine model shows respiratory defects and muscular atrophy

June 2, 2022

Researchers present novel Hermansky-Pudlak syndrome murine model

June 2, 2022

RAGE-silencing RNAi suppresses pulmonary allergic inflammation

May 31, 2022

Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF

May 30, 2022

Sichuan Haisco Pharmaceutical patents ENPP2 inhibitors

May 30, 2022

Pendrin inhibitor ARBM-201 reduces lung injury in acute respiratory distress syndrome model

May 30, 2022

FDA awards orphan drug designation to TTI-101 for IPF

May 27, 2022

ILDONG Pharmaceutical synthesizes new CFTR modulators and/or PDE4 inhibitors

May 18, 2022

AstraZeneca selects IPF target under drug discovery collaboration with BenevolentAI

May 17, 2022

Vertex Pharmaceuticals patents CFTR modulators

May 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...